Print

ANRS VAC 18

Randomised double blinded phase II AIDS vaccine study comparing immunogenicity and safety of 3 doses of lipopeptide (LIPO-5) versus placebo in non infected HIV volunteers (ANRS liVAC 18)

Trial Details:

II Completed
French National Agency for Research on AIDS and viral hepatitis (ANRS) September 01, 2004
LIPO-5 5 lipopeptides containing CTL epitopes from the Gag, Nef, and Pol B
LIPO-5 Protein
France 156
NCT00121758
http://clinicaltrials.gov/ct2/show/NCT00121758